Selecting and also Sequencing Tucatinib as well as T-DXd in HER2 BC and also Mind Metastases

Erika Hamilton, MD: Rita, we spoke a little bit of concerning the [adverse] results we usually see with tucatinib. What regarding trastuzumab deruxtecan [T-DXd] What's the difference? What can we occasionally see there? Rita Nanda, MD: The one aspect patients will most definitely discuss is the hair loss. We all know scalp cooling typically isn't very efficient ideal [
Read More
Komentarze
Prześlij komentarz